Publication
Government of Alberta launches nuclear energy engagement
On August 25, 2025, the Government of Alberta publicly re-affirmed its interest in nuclear energy with the launch of its Nuclear Energy Engagement (the Engagement).
OSHA compliance, investigations and citation appeals
United States | Publication | July 2022
Our OSHA newsletter is a publication of the Norton Rose Fulbright US OSHA team. We provide information on recent developments concerning both the federal and various approved states’ occupational safety and health programs across the nation.
This issue addresses recent enforcement decisions from federal OSHA and updates from multiple state-run OSHA programs.
Featured articles
- US OSHA to pursue enhanced oversight and enforcement for trench work
- MIOSHA conducts employer stand down to address trenching hazards
- OSHA expects to approve Massachusetts’ occupational health and safety plan for government workers
- OSHA proposes to revoke Arizona’s occupational safety and health plan
- State-specific OSHA guidelines: Kentucky
- Commission decision summaries
Previously published articles
- US OSHA extends COVID National Emphasis Program
- US OSHA initiates rulemaking to revise occupational lead exposure standards
- Summer is here: Protect workers from heat dangers
- Susan Harwood Training Grants available for workplace health and safety
- Criminal indictments arise from grain mill explosion
- Cal/OSHA’s revised COVID-19 emergency temporary standard take effect this week
- US OSHA may revoke approval of Arizona’s state OSHA plan
- US OSHA will hold public meeting on whistleblower program improvements
Recent publications
Publication
Health Canada’s proposal to streamline approvals may accelerate biosimilar patent litigation
Health Canada has proposed a major change to the regulation of biosimilar drugs that may accelerate biologic patent litigation in Canada. Following the lead of other jurisdictions, Health Canada has proposed that biosimilar manufacturers no longer be required to conduct phase 3 clinical trials to enter the Canadian market.
Subscribe and stay up to date with the latest legal news, information and events . . .